Sanjay Subramanian Ocugen, Inc. (OCGN) insider trading activity

Sanjay Subramanian is Chief Financial Officer of Ocugen, Inc.. Currently has a direct ownership of 161,125 shares of OCGN, which is worth approximately $116,010. The most recent transaction as insider was on Jan 03, 2022, when has been sold 125,534 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 161K

0% 3M change

0% 12M change

Total Value Held $116,010

Sanjay Subramanian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2022	BUY Grant, award, or other acquisition	-	125,534 Added 43.79%	161,125 Common Stock
Oct 26 2021	SELL Open market or private sale	$110,700 $11.07 p/Share	10,000 Reduced 21.93%	35,591 Common Stock
Oct 15 2021	SELL Open market or private sale	$79,580 $9.96 p/Share	7,990 Reduced 14.91%	45,591 Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$17,498 $2.19 p/Share	7,990 Added 12.98%	53,581 Common Stock
Aug 16 2021	SELL Open market or private sale	$216,600 $7.22 p/Share	30,000 Reduced 39.69%	45,591 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$10,200 $0.34 p/Share	30,000 Added 28.41%	75,591 Common Stock
Jul 15 2021	SELL Open market or private sale	$208,276 $6.7 p/Share	31,086 Reduced 40.54%	45,591 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$10,569 $0.34 p/Share	31,086 Added 28.85%	76,677 Common Stock
Jun 15 2021	SELL Open market or private sale	$217,000 $7.0 p/Share	31,000 Reduced 40.47%	45,591 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$10,540 $0.34 p/Share	31,000 Added 28.81%	76,591 Common Stock
May 14 2021	SELL Open market or private sale	$253,580 $8.18 p/Share	31,000 Reduced 40.47%	45,591 Common Stock
May 14 2021	BUY Exercise of conversion of derivative security	$10,540 $0.34 p/Share	31,000 Added 28.81%	76,591 Common Stock
Apr 29 2021	SELL Open market or private sale	$87,730 $10.98 p/Share	7,990 Reduced 14.91%	45,591 Common Stock
Apr 29 2021	BUY Exercise of conversion of derivative security	$17,498 $2.19 p/Share	7,990 Added 12.98%	53,581 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	$18,151 $0.51 p/Share	35,591 Added 43.84%	45,591 Common Stock

Also insider at

INZY

Inozyme Pharma, Inc. Healthcare

SVP, CFO